Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
Merck & Co (MRK) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Merck & Co's actual EPS was $2.19, beating the estimate of $2.03 per share, resulting in a 7.69% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
